INFI stock

Infinity Pharmaceuticals (NASDAQ:INFI) soared 61%, and over the week, the biotech name has been a big mover taking investors on

Shares of Clinical stage biopharmaceutical company, Infinity Pharmaceuticals Inc (NASDAQ:INFI) fell by 31.50% to $1.52 on July 27, 2021 following

Infinity Pharmaceuticals Inc. (NASDAQ:INFI) dropped 15% last week on no news. Recently, the company announced its 2020 financial results and